In addition, predictive models such as the age, male, albumin-bilirubin, platelets (aMAP) score and the FibroScan-AST (FAST) score have been demonstrated as valuable tools for estimating HCC risk, providing clinicians with critical guidance for risk stratification [11–13]. This evidence concerns the gene ALB and hepatocellular carcinoma.